Abstract:The cellular prion protein, PrP C , has been postulated to function as a receptor for α-synuclein, potentially facilitating cell-to-cell spreading and/or toxicity of α-synuclein aggregates in neurodegenerative disorders such as Parkinson's disease. Previously, we generated the "Salt (S)" and "No Salt (NS)" strains of α-synuclein aggregates that cause distinct pathological phenotypes in M83 transgenic mice overexpressing A53T-mutant human α-synuclein. To test the hypothesis that PrP C facilitates the propagation of α-synuclein aggregates, we produced M83 mice that either express or do not express PrP C . Following intracerebral inoculation with the S or NS strain, the absence of PrP C in M83 mice did not prevent disease development and had minimal influence on α-synuclein strain-specified attributes such as the extent of cerebral α-synuclein deposition, selective targeting of specific brain regions and cell types, the morphology of induced α-synuclein deposits, and the structural fingerprints of protease-resistant α-synuclein aggregates. Likewise, there were no appreciable differences in disease manifestation between PrP C -expressing and PrP C -lacking M83 mice following intraperitoneal inoculation of the S strain. Interestingly, intraperitoneal inoculation with the NS strain resulted in two distinct disease phenotypes, indicative of α-synuclein strain evolution, but this was also independent of PrP C expression. Overall, these results suggest that PrP C plays at most a minor role in the propagation, neuroinvasion, and evolution of α-synuclein strains in mice that express A53T-mutant human α-synuclein. Thus, other putative receptors or cell-to-cell propagation mechanisms may have a larger effect on the spread of α-synuclein aggregates during disease. During Parkinson's disease and related neurodegenerative disorders, the protein α-synuclein clumps together in the brain to form aggregates. α-Synuclein aggregates can spread between cells, and this process is believed to underlie disease progression. Thus, blocking the spread of α-synuclein aggregates may be a good therapeutic strategy for preventing the progression of Parkinson's disease. The details of how α-synuclein aggregates spread from cell to cell in the brain remain unclear, but it has been proposed that the cellular prion protein (PrP C ) may facilitate spreading by acting as a receptor for α-synuclein aggregates. However, this notion remains controversial. In this study, we compared the spread of α-synuclein aggregates within and to the brain in mice that either possessed or lacked PrP C . We found that the spreading of α-synuclein aggregates was largely independent of the presence of PrP C . This suggests that PrP C may not be an effective therapeutic target for attenuating the spread of α-synuclein aggregates in Parkinson's disease.

Variants in Lrrk2 and Snca deficiency do not alter the course of primary encephalitis due to neurotropic reovirus T3D in newborn mice

Reversible Bilateral Striatal Lesions Following Mycoplasma Pneumoniae Infection Associated with Elevated Levels of Interleukins 6 and 8.

Sialic acid and PirB are not required for targeting of neural circuits by neurotropic mammalian orthoreovirus

Formation of templated inclusions in a forebrain α-synuclein mouse model is independent of LRRK2

Environmental exposures and familial background alter the induction of neuropathology and inflammation after SARS-CoV-2 infection

LRRK2 activity does not dramatically alter α-synuclein pathology in primary neurons

Mutations in LRRK2 impair NF-κB pathway in iPSC-derived neurons

Passive-Immunity to Fatal Reovirus Serotype 3-Induced Meningoencephalitis Mediated by Both Secretory and Transplacental Factors in Neonatal Mice

Mutant LRRK2 in lymphocytes regulates neurodegeneration via IL-6 in an inflammatory model of Parkinson’s disease

Astrocyte inflammatory signaling mediates α-synuclein aggregation and dopaminergic neuronal loss following viral encephalitis

Evaluation of Neuroinflammatory Contribution to Neurodegeneration in LRRK2 Drosophila Models

Revoking the Seize Order: Preventing Spontaneous Seizures With AAV in a CLN2 Mouse Model

Dopaminergic Neurons Differentiated from LRRK2 I1371V-Induced Pluripotent Stem Cells Display a Lower Yield, α-Synuclein Pathology, and Functional Impairment

α-Synuclein Strain Propagation is Independent of Cellular Prion Protein Expression in Transgenic Mice

α-Synuclein strain propagation is independent of cellular prion protein expression in a transgenic synucleinopathy mouse model

The R1441C-Lrrk2 mutation induces myeloid immune cell exhaustion in an age- and sex-dependent manner in mice

The LRRK2 kinase substrates RAB8a and RAB10 contribute complementary but distinct disease-relevant phenotypes in human neurons

Cell autonomous role of leucine-rich repeat kinase in protection of dopaminergic neuron survival

Loss of primary cilia and dopaminergic neuroprotection in pathogenic LRRK2-driven and idiopathic Parkinson's disease

Age-specific dynamics of neutralizing antibodies, cytokines, and chemokines in response to La Crosse virus infection in mice

R1441C and G2019S LRRK2 knockin mice have distinct striatal molecular, physiological, and behavioral alterations